Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03289065 · ClinicalTrials.gov registry record
Fabry Outcome Survey (FOS)
A clinical trial of Fabry Disease, sponsored by Shire.
- Completed
- Registry status
- 4,000
- Enrollment target
- 1
- Study location
NCT03289065 is a study of Fabry Disease that has completed, run by Shire. The registered enrollment target is 4,000 participants, above the 418-participant average among 32 other Fabry Disease trials with a reported enrollment target (857% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03289065, a study of Fabry Disease, has completed, sponsored by Shire.
- COMPLETED
- Registry status
- 4,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to collect data that will increase understanding of Fabry disease history and progression, in treated and untreated patients with Fabry disease. The data from FOS may provide guidance to healthcare professionals about disease treatment options.
Conditions Studied
Study Locations (1)
Massachusetts
- Shire - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2001-04-01 |
| Est. Completion | 2021-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03289065
The ClinicalTrials.gov registry entry for NCT03289065 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 4,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 418-participant average among 32 other Fabry Disease trials with a reported enrollment target (857% higher). The listed sponsor is Shire, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Fabry Disease appearing as the primary indexed condition, and to 0 interventions.
NCT03289065 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03289065 about?
NCT03289065 is a clinical study titled "Fabry Outcome Survey (FOS)". The purpose of this study is to collect data that will increase understanding of Fabry disease history and progression, in treated and untreated patients with Fabry disease. The data from FOS may provide guidance to healthcare professionals about disease treatment options.
What is the current status of trial NCT03289065?
This trial is currently completed. The enrollment target is 4,000 participants. The study started on 2001-04-01. Estimated completion is 2021-09-30.
What conditions does trial NCT03289065 study?
This clinical trial studies the following conditions: Fabry Disease.
Who is sponsoring clinical trial NCT03289065?
This trial is sponsored by Shire, which has 245 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03289065 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fabry Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Maternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Assessing the Safety of Elfabrio® in Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding
RECRUITING
-
Natural History and Structural Functional Relationships in Fabry Renal Disease Treatment Outcomes(Changes)in Fabry Renal Disease Study
RECRUITING
-
A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants
RECRUITING · Phase 3
-
A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease
RECRUITING · Phase 2
-
A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients
RECRUITING
-
A Global Prospective Observational Study of Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.